[Hepatic changes in different hormone replacement therapies in climacteric]
- PMID: 7668064
[Hepatic changes in different hormone replacement therapies in climacteric]
Abstract
Measurements of liver enzymes (ASAT, ALAT, GGT, AP) and SHBG were carried out in 128 postmenopausal women during 12 months of different hormone replacement therapies. There was no negative effect on these liver enzymes. ASAT, ALAT, GGT and AP decreased during the 12 months of treatment. Transdermal replacement therapy did not induce a higher level of SHBG.
Similar articles
-
[Effect of hormone substitution therapy on AT III in women in the climacteric].Zentralbl Gynakol. 1991;113(11):639-44. Zentralbl Gynakol. 1991. PMID: 1656654 German.
-
[Hormone substitution in climacteric. Position of the German Menopause Society].Zentralbl Gynakol. 1995;117(6):B1-4. Zentralbl Gynakol. 1995. PMID: 7645352 German. No abstract available.
-
Effect of progestins on IGF-I serum level in estrogen-treated postmenopausal women.Zentralbl Gynakol. 1997;119 Suppl 2:7-11. Zentralbl Gynakol. 1997. PMID: 9361392 Review.
-
Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.Maturitas. 2008 Jul-Aug;60(3-4):185-201. doi: 10.1016/j.maturitas.2008.07.007. Epub 2008 Sep 5. Maturitas. 2008. PMID: 18775609 Review.
-
Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.J Reprod Med. 2001 Nov;46(11):962-8. J Reprod Med. 2001. PMID: 11762152 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous